An Overview of Risk and Advantages of Peritoneal Dialysis and Hemodialysis
|
|
- George Casey
- 5 years ago
- Views:
Transcription
1 Vol. 4, Issue 2, pp: ( ), Month: October March 2017, Available at: An Overview of Risk and Advantages of Peritoneal Dialysis and Hemodialysis 1 Albaraa Mohammad J Madkhali, 2 Abdullatif Alhassan A Fathi, 3 Albaraa Ahmed F Juraybi, 4 Khalid Awaji M Jammali, 5 Ahmed Abdullah Ahmed Hakami, 6 Omar Abdulaziz Yahya Madkhali, 7 Fahad Mousa Jawman Wasili, 8 Ahmed Ibrahim Ibrahim Alkhawaji, 9 Nasir Abdullah Mgboul, 10 Rami Mohammed Yahya Alfaifi Abstract: Peritoneal dialysis (PD) and hemodialysis (HD) are dialysis options for end-stage renal disease patients in whom preemptive kidney transplantation is not possible. The selection of PD or HD will usually be based on patient motivation, desire, and geographic distance from an HD unit, physician and/or nurse bias, and patient education. Unfortunately, many patients are not educated on PD before beginning dialysis.the main aim of this review is to list the advantages and risks of peritoneal dialysis and hemodialysis. Keywords: Peritoneal dialysis (PD), chronic kidney disease (CKD). 1. INTRODUCTION Integrated care models of chronic kidney disease (CKD) and end-stage renal disease (ESRD) stress shifts between treatment methods (hemodialysis)[hd], peritoneal dialysis [PD], and kidney transplantation) and the possibility that a specific patient will, in his/her life time with CKD/ESRD, experience more than among these methods. For most patients, successful kidney hair transplant is the very best treatment for ESRD. The absence of available donor organs, comorbid conditions, and patient option prevent trans- plantation in many patients, thereby making chronic dialysis the only option for some beginning renal repositioning treatment. Medical and social conditions in addition to geographical considerations and patient choice ought to dictate the choice of PD (constant ambulatory PD or constant biking PD) or hemodialysis (HD), but patient choice need to always be the main consider that decision. Patient choice needs appropriate method education, which, sadly, is not always the case. As a consequence, physician choice and experience and reimbursement issues may also influence modality choice (1-4). Implicit in the decision to start HD or PD is a consideration of the threats and benefits of each method, and those concerns will be the focus of this discussion. 2. METHODOLOGY We searched Ovid versions of MEDLINE, EMBASE and PUDMED up to 2015, As well as the Cochrane Database of Systematic Reviews and Cochrane Controlled Trials Register. MESH terms used were 'PERITONEAL' and 'HEMODIALYSIS', 'DIALYSIS' and 'CHRONIC KIDNEY DISEASE'. Further terms were included as text words. A high sensitivity "therapy" (trials) filter was applied to the EMBASE search. No other limits were applied to any of the searches. In addition, we hand searched the reference lists of retrieved full-text papers. Risks and Benefits of PD versus HD: 3. RESULTS AND DISCUSSION Table 1 reveals a few of the primary benefits of each modality. We are not particularly considering home HD, however much of the basic advantages of PD noted in the table also apply to house HD. Preliminary method choice need to for the Page 1247
2 most parts be patient/family directed, with primary factors to consider concentrated on lifestyle and social problems such as patient autonomy, geographic place as it impacts transport to and from the dialysis center, living circumstance, patient motivation, and patient and family employment. Patient education about modality choices is needed for notified decision making and, in most cases, will be somewhat depending on physician input and motivation. Regrettably, United States nephrologist training in PD is often insufficient (5), and although many nephrologists think at least 40% of ESRD patients should be on PD (6), less than 10% of present US dialysis patients are on PD (7). Bundling of dialysis services and repayment for pre- dialysis education might increase the varieties of patients on PD over the next few years (4). In basics, when patients are needed to be seen regularly prior to dialysis and informed about PD, up to 45% of patients choose PD (8). Distance from an HD center is a main factor in the option of PD, accounting for 25% of the variability of dialysis technique option in a 1996 to 1997 study of 3793 event dialysis patients (1). Younger, white, employed, more educated patients in this research study were likely to pick PD over in-center HD (1). Because patient survival and acceptable quality of life are the ultimate goals of renal replacement treatments, it is very important to compare mortality and morbidity in patients on PD and HD. The influence of dialysis modality on patient survival is rather controversial, with early research studies showing a 19% greater adjusted death rate in PD patients (9). However, subsequent research studies demonstrated similar survival in PD and HD patients and emphasized that patient comorbidity, age, and reason for ESRD were the primary factors impacting survival (10). More current research studies have actually explained improved survival in PD patients, particularly in the very first 1 to 2 years of ESRD (11,12). After 1.5 to 2 years on dialysis, the threat of death in PD patients ends up being equivalent to or greater than that in HD patients, depending on patient factors such as age, diabetes, and other comorbidities. Two current research studies revealed the negative results of main venous catheter (CVC) on patient survival. (13,14) Perl and associates demonstrated comparable survival in PD and HD patients who started with an arteriovenous fistula (AVF) or arteriovenous graft (AVG) (90-day survival: 7.4% for PD and 6.1% for HD- AVF/AVG), but considerably even worse survival for HD patients starting dialysis with a CVC (15.6% survival, 13). Another little study of 123 patients beginning dialysis in an unintended style showed comparable 6-month survival for HD and PD patients however a greater relative threat of bacteremia in the HD patients, suggesting "acutestart PD" is a practical alternative for late recommendation patients (14).The observed early PD survival benefit might in part be due to enhancing survival of PD patients in general, possibly due to technical advances and increasing experience of nurses and nephrologists with PD (4). PD program experience stays an impact on patient and method success in PD, with more knowledgeable( big programs with more patients) programs reporting lower rates of strategy failure and patient mortality (15). In addition, maintenance of residual kidney function might contribute to minimized death, and many studies report better conservation of residual kidney function in patients on PD compared with patients on HD (16). Some research studies have actually reported higher death in PD patients with underlying heart disease (17,18). Other studies have actually kept in mind a higher occurrence of hemorrhagic stroke in patients on HD although a USRDS analysis concluded that the risk of death from stroke was greater in PD patients despite a lower frequency of preexisting cerebrovascular disease (19). Patient comorbidity, including diabetes and age, influences death. Death might be lower in PD patients throughout the very first 1 to 2 years of dialysis, method failure with PD stays fairly high and adversely impacts patients' quality of life owing to the requirement for interventions (new access) and transfer to HD. Despite significant reductions in peritonitis rates, infection stays the primary reason for transfer to HD. In one prospective study of 28 dialysis centers, 25% of PD patients moved to HD, with 70% of those moving within 2 years of beginning PD (20). Re- current peritonitis may also lead to membrane failure, and ultrafiltration failure is the reason for 2% to 14% of transfers from PD (21). An analysis of USRDS information recommends enhanced method survival in current accomplices of PD patients (22). Additional threats of PD are displayed in Table 1 and consist of weight patient, caretaker and gain burnout, and, with the loss of recurring kidney function, possible inadequate little solute clearance. Dialysis adequacy is assessed on a routine basis in both HD and PD patients. Although the day-to-day small urea clearance on PD is significantly less than the urea clearance of a single HD treatment, the constant nature of PD supplies adequate total clearance as measured by weekly kt/v. Some would recommend that the more frequent physician sees of HD patients (PD patients are generally seen regular monthly and HD patients as much as 4 times each month) is a benefit of HD over PD. Nevertheless, there are no information revealing improved patient survival or reduced morbidity related to the frequency of physician sees. For some patients, HD offers a chance for socializing and advancement of a caring community of good friends and caretakers interested in the patient and his or her well-being. For numerous PD patients, the support of the home dialysis nurses may supply a comparable experience. Caregiver burnout and depression are less Page 1248
3 with HD patients (23). As the dialysis population is significantly older and less functionally independent, caregiver requirements and action presume an essential consideration in dialysis results and should have more attention and research study. A few research studies have revealed less postponed graft function after kidney hair transplant in PD patients compared with HD patients (24,25). Factors involved may include patient volume status and recurring kidney function at the time of transplant. A recent study revealed a 10% lower (P ) all-cause mortality in patients on PD compared with those on HD prior to transplantation (26). Access in PD and HD: Table 1 highlights the risks of HD and PD, and amongst the most common are access-related concerns. HD is practically constantly utilized as preliminary treatment when patients present with acutely found CKD, mostly because of the obtaincapability and suitability of CVC for instant HD access. The dangers associated with CVC are substantial, with a 2- to 3- fold boost in mortality, a 5- to 10-times increase in severe infection, and increased rates of hospitalization in HD patients using CVC for HD access (27). In addition, long-lasting CVC usage is associated with a greater number of vascular procedures and higher incidence of insufficient dialysis (28,29). Some researchers have suggested that catheters may likewise contribute indirectly to high patient mortality by acting as an instigator of a persistent inflammatory condition that predisposes to morbidity and death (30,31). The finding of higher CRP levels in HD patients without obvious infection but with CVC has actually raised this possibility and issue (30,31). Moreover, long-term CVC gain access to for HD is associated with osteomyelitis, septic arthritis, endocarditis, bad quality of life, and central vein stenosis that may limit future alternatives for arteriovenous access (27,29). Efforts to decrease the risk of catheters for HD gain access to have focused on early nephrology recommendation, development of a multidisciplinary dialysis access team, and patient and nephrologist education (27,32) but CVC use remains high in the United States. Some have actually recommended that patients who decline production of an arteriovenous fistula or graft and decide to continue using a CVC as HD access need to be needed to sign an in- formed rejection of AVF type and ultimately be referred to another nephrologist for care (27). In such instances, a quality care issue is cited as the factor for refusing ongoing care of a patient who declines AVF or AVG placement (27). Although such action may be more extreme than numerous nephrologists are willing to consider, it is incumbent on nephrologists as a group to make all efforts to reduce using dialysis catheters. Although a range of PD catheters are offered, the distinctions amongst them are minor, and the decision to use one catheter over another depends primarily on the choices of the physician placing the catheter. Function and infection rates are usually comparable for all available PD catheters although fairly little studies may advocate for certain catheters or implantation techniques(eg, Tenckhoff vs swan-neck catheters, surgical vs laparoscopically implanted, buried vs nonburied) (33,35) The absence of surgical training in PD catheter placement might be a concern for some programs (36). PD catheters are placed in the abdominal area, but for some patients (obese, those with ostomies, children), the presternal catheter exit site area might be more effective (37). Complications related to PD catheters may include bad drainage and infection. Infection stays the most typical cause for transfer to HD, but in effective PD programs, peritonitis rates are now 1 every 20 to 37 mo/patient (4,38). Moreover, compared with CVC-associated infections, PD-associated catheter infections hardly ever result in death and are less regularly connected with hospitalization (4). Quality enhancement programs to analyze infection rates, triggers, and preventive procedures are essential to any PD program and are significantly being adjusted by HD programs to lower infection rates. Table 1 Risks and Benefits of PD and HD Benefits PD -Survival years 1 2 -Patient autonomy -Patient satisfaction -Maintenance of RRF -Lower cost -Less delayed graft function post transplant Risks -High technique failure (membrane failure, infection) -Weight gain -Patient and caregiver burnout HD - Less patient responsibility -Community/socialization -Infection (bacteremia, sepsis) -Access complications Page 1249
4 Costs and Patient Satisfaction in PD and HD: Although there are few research studies analyzing dialysis patients' fulfillment, PD patients normally report higher satisfaction than in-center HD patients (39,40). Explanations for this might connect to the patients themselves and their viewed quality of life and self-reliance (typically greater among PD patients) but might likewise show fundamental qualities in patients that lead them to choose a home-based technique. Surprisingly, PD patients are also more pleased with their treatment providers (nurse and physician) in spite of less direct exposure to nephrologists than that experienced by in-center HD patients who are typically seen weekly. The accessibility of the PD nurse and the close relationship that typically establishes in between PD nurses and their patients may foster patient self-confidence and assistance in a manner that leads to more complete satisfaction than that experienced by in-center HD patients. The lack of regulated studies examining patient satisfaction and the confounding problem of choice predisposition recommends additional study of this problem is required. The expense of treatment to society is relevant since dialysis is a Medicare benefit in the United States. PD remains less costly than in-center HD, with each year patient expenses of $53,446 and $73,008, respectively, as exposed by Medicare data.7 Under personal insurance coverage, PD was also significantly less costly than HD ($173,507 vs $129,997, P ) in the first year after starting dialysis in 463 dialysis patients, in part because hospitalization rate was lower amongst PD patients (41). However, before January 2011, the expense of medications administered throughout dialysis was generally higher for HD patients. With the inception of dialysis services bundling, costs of intravenous medications given throughout HD will likely fall, and hence, The total treatment expense of HD need to likewise fall. Owing to the costs of devices and, notably, staff required in the HD unit, PD treatment costs are most likely to remain lower than HD costs, but the overall expense difference between the 2 modalities may narrow. There is a specific payment for professional services provided during training for house dialysis that can be billed by nephrologists and might act as a financial reward to develop house dialysis programs. There is no comparable payment for in-center HD. Clinical summary A PD survival advantage is seen early in the course of renal replacement therapy, but after 1 to 2 years, patient survival on PD or HD is equivalent and influenced by comorbidity and age. The high rate of technique failure in PD remains primarily a function of infectious complications although peritonitis rates are now low in experienced PD programs. Infection and access issues are the most common problems for patients on HD, and, especially for HD patients using CVC, high mortality and morbidity are to be expected. Recent changes in reimbursement for dialysis education as well as bundling of dialysis services may lead to a renewed interest in PD in the United States. Nephrologists efforts should be focused on educating themselves and their patients about the opportunities for home modality therapies and reducing the reliance on catheters for long- term HD access. 4. CONCLUSION The choice of PD or HD will normally be based upon patient motivation, desire, geographical distance from an HD unit, nurse and/or doctor bias, and patient education. A PD survival advantage is seen early in the course of renal replacement therapy, but after 1 to 2 years, patient survival on PD or HD is comparable and influenced by comorbidity and age. The high rate of strategy failure in PD remains mainly a function of contagious problems although peritonitis rates are now low in experienced PD programs. Infection and access issues are the most common problems for patients on HD, and, especially for HD patients using CVC, high mortality and morbidity are to be anticipated. Factor to consider of PD as a bridge for gain access to maturation and initial treatment in late recommendation patients should be entertained in an effort to prevent CVC. Recent modifications in reimbursement for dialysis education in addition to bundling of dialysis services might result in a renewed interest in PD in the United States. Nephrologists' efforts need to be focused on educating themselves and their patients about the chances for home method therapies and minimizing the dependence on catheters for long-term HD gain access to. Page 1250
5 REFERENCES [1] Stack AG. Determinants of modality selection among incident US dialysis patients: results from a national study. J Am Soc Nephrol. 2002;13: [2] Miskulin DC, Meyer KB, Athienites NV, et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE study. Am J Kidney Dis. 2002;39: [3] Jager KJ, Korevaar JC, Dekker FW. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in the Netherlands. Am J Kidney Dis. 2004;43: [4] Chaudhary K, Sangha H, Khanna R. Peritoneal dialysis first: rationale. Clin J Am Soc Nephrol. 2011;6: [5] Linas S. Dialysis training in the United States. Am J Kidney Dis. 2002;40: [6] Ledebo I, Ronco C. The best dialysis therapy? Results from an inter- national survey among nephrology professionals. Nephrol Dial Transplant Plus. 2008;1: [7] U.S. Renal Data System. USRDS 2009 Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Disease; [8] Golper T. Patient education: can it maximize the success of therapy? Nephrol Dial Transplant. 2001;16:S20-S24. [9] Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995;6: [10] Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004;66: [11] Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to hemodialysis. Nephrol Dial Transplant. 2002;17: [12] Weinhandl ED, Foley RN, Gilbertson DT, et al. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol. 2010;21: [13] Perl J, Wald R, McFarlane P, et al. Hemodialysis vascular access modifies the association between dialysis modality and survival. Clin J Am Soc Nephrol. 2011;22: [14] Koch M, Kohnle M, Trapp R, Haastert B, Rump LC, Akers S. Com- parable outcome of acute unplanned peritoneal dialysis and hae- modialysis. Nephrol Dial Transplant. In press. [15] Schaubel DE, Blake PG, Fenton SS. Effect of renal center characteristics on mortality and technique failure on peritoneal dialysis. Kidney Int. 2001;60: [16] Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11: [17] Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Im- pact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int. 2003;64: [18] Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol. 2003;14: [19] Mattana J, Effiong C, Gooneratne R, Singhal PC. Risk of fatal cerebrovascular accident in patients on peritoneal dialysis versus hemodialysis. J Am Soc Nephrol. 1997;8: [20] Jaar BG, Plantinga LC, Crews DC, et al. Timing, causes, predictors, and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study. BMC Nephrol. 2009;10:3. [21] Margetts PJ, Churchill DN. Acquired ultrafiltration dysfunction in peritoneal dialysis patients. J Am Soc Nephrol. 2002;13: [22] Mehrotra R, Chiu YW, Kalantar-Zadeh K, Vonesh E. The outcome of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int. 2009;76: Page 1251
6 [23] Belasco A, Barbosa D, Bettencourt AR, et al. Quality of life of family caregivers of elderly patients on hemodialysis and peritoneal dialysis. Am J Kidney Dis. 2006;48: [24] Vanholder R, Herring P, Loo AV, et al. Reduced incidence of acute renal graft failure in patients treated with peritoneal dial- ysis compared with hemodialysis. Am J Kidney Dis. 1999;33: [25] Goldfarb-Rumyantzev AS, Hurdle JF, Scandling JD, et al. The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival. Am J Kidney Dis. 2005;46: [26] Schwenger V, Dohler B, Morath C, Zeier M, Opelz G. The role of pretransplant dialysis modality on renal allograft outlook. Nephrol Dial Transplant. In press. [27] Rehman R, Schmidt RJ, Moss AH. Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol. 2009;4: [28] Polkinghorne KR, McDonald SP, Atkins RC, et al. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol. 2004;15: [29] Marr KA, Sexton DJ, Conlon PJ, et al. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med. 1997;127: [30] Hung A, Pupim L, Yu C, et al. Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization. Hemodial Int. 2008;12: [31] Lacson E, Lazarus JM, Himmelfarb J, et al. Balancing fistula first with catheters last. Am J Kidney Dis. 2007;50: [32] Lok CE. Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007;2: [33] Strippoli GF, Tong A, Johnson D, et al. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol. 2004;15: [34] Crabtree JH. Selected best demonstrated practices in peritoneal dialysis access. Kidney Int. 2006;103:S27-S37. [35] Brown PA, McCormick BB, Knoll G, et al. Complications and catheter survival with prolonged embedding of peritoneal dialysis catheters. Nephrol Dial Transplant. 2008;23: [36] Wong LP, Liebman SE, Wakefield KA, Messing S. Training of sur- geons in peritoneal dialysis catheter placement in the United States: a national survey. Clin J Am Soc Nephrol. 2010;5: [37] Zimmerman DG. Presternal catheter design: an opportunity to cap- italize on catheter immobilization. Adv Perit Dial. 2009;26: [38] Neissim SJ, Bargman JM, Jassal SV. Relationship between double-cuffed and single-cuffed PD catheters and the risk of peritonitis. Nephrol Dial Transplant. 2010;25: [39] Rubin HR, Fink NE, Plantinga LC, et al. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA. 2004;291: [40] Fadem SZ, Walker DR, Abbott G, et al. Satisfaction with renal replacement therapy and education: the American Association of Kidney Patients survey. Clin J Am Soc Nephrol. 2011;6: [41] Berger A, Edelsberg J, Inglese GW, et al. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. Am J Manag Care. 2009;15: Page 1252
The CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES
Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationAJNT. Original Article
. 2012 May;5(2):81-6 Original Article AJNT Reaching Target Hemoglobin Level and Having a Functioning Arteriovenous Fistula Significantly Improve One Year Survival in Twice Weekly Hemodialysis Sarra Elamin
More informationRenal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications
Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc. 2018 non-mips Measure Specifications Last updated January 2, 2018 RPAQIR1: Angiotensin Converting Enzyme (ACE)
More informationExperts in all modalities The Expanding Role of PD Trends and Advances That Have Increased the Viability and Utilization of Peritoneal Dialysis
Experts in all modalities The Expanding Role of PD Trends and Advances That Have Increased the Viability and Utilization of Peritoneal Dialysis Todd W.B. Gehr, M.D. Professor and Chairman, Division of
More informationISPD Asian Chapter Newsletter International Society for Peritoneal Dialysis (ISPD)
ISPD Asian Chapter Newsletter International Society for Peritoneal Dialysis (ISPD) Volume 6, Issue 2; August 2008 From the Editorial Office Dear All, Welcome back from the 2008 ISPD congress held in Istanbul,
More informationASDIN 7th Annual Scientific Meeting
Strategies for Decreasing the Use of Hemodialysis Catheters ASDIN 7 th Annual Scientific Meeting Outline Late referral Primary failure Why Not PD? Summary Micah Chan MD MPH FACP Assistant Professor of
More informationEffects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes
Original Investigation Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes Eduardo Lacson Jr, MD, MPH, Weiling Wang, MS, Cari DeVries, Keith
More informationDialysis Initiation and Optimal Vascular Access: Outcomes and Mortality
Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage
More informationExamining Facility Level Data
Examining Facility Level Data for the USRDS Yi Li, PhD Professor of Biostatistics, University of Michigan, Ann Arbor Director, Kidney Epidemiology and Cost Center (KECC) Co Deputy Director, United States
More informationPreservation of Veins and Timing for Vascular Access
Preservation of Veins and Timing for Vascular Access Vassilis Liakopoulos, MD, PhD Department of Nephrology School of Medicine University of Thessaly Greece Hemodialysis VA A sound long-term dialysis access
More informationChapter Five Clinical indicators & preventive health
Chapter Five Clinical indicators & preventive health The painter who draws merely by practice and by eye, without any reason, is like a mirror which copies every thing placed in front of it without being
More informationTHERE S A BIG DIFFERENCE BETWEEN SIMPLY SURVIVING AND REALLY LIVING.
THERE S A BIG DIFFERENCE BETWEEN SIMPLY SURVIVING AND REALLY LIVING. IT S CALLED PD. Peritoneal dialysis, or PD, is a different kind of dialysis. PD is a choice that could help you feel like you re living,
More informationINTEGRATED CARE. Table 1. RVCARE core components and goals. Figure 2. Patients who choose PD in the RVCARE Program
The first 120 days of crucial care: Strategies for managing incident dialysis patients Naveena Reddy, MS, RD Farzeen Sukheswalla, MS, RD George R. Aronoff, MD, MS, FACP. The Renal ACO New Approaches to
More informationPeritoneal dialysis in the US: Evaluation of outcomes in contemporary cohorts
http://www.kidney-international.org & 2006 International Society of Nephrology Peritoneal dialysis in the US: Evaluation of outcomes in contemporary cohorts S Mujais 1 and K Story 1 1 Renal Division, Baxter
More informationConcern about the decreasing use of peritoneal dialysis
Page 1 of 8 Peritoneal Dialysis International Peritoneal Dialysis International, Vol. 30, pp. doi: 10.3747/pdi.2008.00277 0896-8608/10 $3.00 +.00 Copyright 2010 International Society for Peritoneal Dialysis
More informationIncident Hemodialysis
The Acute Kidney Injury Group Modifying the Highest Mortality Rate in the Major AKI Adverse Outcome Other than Death: Loss ESRD & Incident Hemodialysis The EVA QI Program Integrated Inpatient Early Vascular
More informationTechnical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access
Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Louise Moist Associate Professor Lead Vascular Access Ontario Renal Network Schulich School of Medicine University
More informationTRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA
& TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA 2002-2008 Halima Resić* 1, Enisa Mešić 2 1 Clinic for Hemodialysis, University of Sarajevo Clinics Centre, Bolnička 25, 71000 Sarajevo, Bosnia
More informationA population-based approach indicates an overall higher patient mortality with peritoneal dialysis compared to hemodialysis in Korea
http://www.kidney-international.org & 2014 International Society of Nephrology clinical investigation see commentary on page 877 A population-based approach indicates an overall higher patient mortality
More informationEnd-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology
End-Stage Renal Disease Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology ESRD : Life with renal replacement therapy CASE: 18 month old male with HUS develops ESRD PD complicated
More informationASDIN 8th Annual Scientific Meeting
Fistula First Breakthrough Initiative Fistula First Breakthrough Initiative Marianne Neumann, RN, CNN FFBI Clinical Lead New Orleans, LA February 26, 2012 Initiated in 2003 by CMS, Goals Include: to ensure
More informationLesson #7: Quality Assessment and Performance Improvement
ESRD Update: Transitioning to New ESRD Conditions for Coverage Student Manual Lesson #7: Quality Assessment and Performance Improvement Learning Objectives At the conclusion of this lesson, you will be
More informationSurvival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system
http://www.kidney-international.org & 2014 International Society of Nephrology see commentary on page 884 of propensity matched incident peritoneal and hemodialysis patients in a United States health care
More informationmorbidity & mortality
morbidity & mortality esrd introduction of ESRD treatment. We examine these concerns throughout the ADR, particularly in Chapter One. This year we focus on infectious complications, especially those related
More informationNarender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,
More informationAcceptance onto dialysis guidelines: St George Hospital
Acceptance onto dialysis guidelines: St George Hospital The following information is a guideline to support clinicians in decision making regarding acceptance onto dialysis. A review of international guidelines
More informationMeasure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety
Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY This is a
More informationAndrea Pizutti, LCSW Gayle Hall, BSN, RN, CNN Regional Operations Director Area Director Davita NxStage Kidney Care
Andrea Pizutti, LCSW Regional Operations Director Davita Gayle Hall, BSN, RN, CNN Area Director NxStage Kidney Care 1 Compare and contrast Home Dialysis Therapies Describe the End Stage Renal Disease patient
More informationNATIONAL QUALITY FORUM Renal EM Submitted Measures
NATIONAL QUALITY FORUM Renal EM Submitted Measures Measure ID/ Title Measure Description Measure Steward Topic Area #1662 Percentage of patients aged 18 years and older with a diagnosis of CKD ACE/ARB
More informationState Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE
Dear State Surveyor: State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE This report is designed to provide a comparative summary of treatment patterns and patient outcomes for
More informationComparisons between hemodialysis (HD) and peritoneal
Hemodialysis and Peritoneal Dialysis: Patients Assessment of Their Satisfaction with Therapy and the Impact of the Therapy on Their Lives Erika Juergensen, Diane Wuerth, Susan H. Finkelstein, Peter H.
More informationTITLE: First Initiative Peritoneal Dialysis versus Hemodialysis for the Treatment of Renal Failure: A Review of Clinical Effectiveness and Guidelines
TITLE: First Initiative Peritoneal Dialysis versus Hemodialysis for the Treatment of Renal Failure: A Review of Clinical Effectiveness and Guidelines DATE: 08 February 2016 CONTEXT AND POLICY ISSUES Hemodialysis
More informationUtopia Health Career Center, LLC. Do not distribute without permission.
Introduction What is dialysis and a brief history. What laws govern dialysis treatments. How to ensure high quality care for patients. How to behave in a professional way. How to become certified. We don
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES
Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationPatient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case control study
http://www.kidney-international.org & 2006 International Society of Nephrology Patient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case control study S Mujais
More informationTransition between home dialysis modalities another piece in the jigsaw of the integrated care pathway.
Transition between home dialysis modalities another piece in the jigsaw of the integrated care pathway. Mark Lambie and Simon J Davies Health Services Research Unit, Institute for Science and Technology
More informationUrgent start PD: Putting the person first
Urgent start PD: Putting the person first Arsh Jain MD, FRCPC, MSc ADC 2019 Who can we target with urgent start PD? Late or not referred Early referral Urgent dialysis start HD catheter Facility HD Who
More informationTalking with Patients About Home Therapies
Talking with Patients About Home Therapies Sherri L. Bresn BS, BSN, RN, CNN 1 This presentation is not intended to replace the medical diagnosis, and/or prescription for therapy as determined by a practicing
More informationFOUR. Clinical Indicators of Care
Clinical Indicators of Care T FOUR The great questions of the time are not decided by speeches and majority decisions but by iron and blood. Otto von Bismarck, Speech to the Prussian Diet 78 ž 2000 ATLAS
More informationStaff-Assisted Home Hemodialysis
Medical Coverage Policy Staff-Assisted Home Hemodialysis Table of Contents Coverage Policy... 1 Overview... 1 General Background... 2 Coding/Billing Information... 4 References... 4 Effective Date...11/15/2017
More informationFaculty of Dentistry, Wroclaw Medical University, Wroclaw, Poland 3. diabetic patients hemodialysis peritoneal dialysis survival
Postepy Hig Med Dosw (online), 2013; 67: 1076-1082 e-issn 1732-2693 www.phmd.pl Original Article Received: 2013.06.24 Accepted: 2013.10.07 Published: 2013.11.20 Different mortality predictor pattern in
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Blood urea sampling methods GUIDELINES
Date written: November 2004 Final submission: July 2005 Blood urea sampling methods GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions are
More informationKDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription. January 25 28, 2018 Madrid, Spain
KDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription January 25 28, 2018 Madrid, Spain Kidney Disease: Improving Global Outcomes (KDIGO) is an international organization
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in ESRD patients, with atherosclerotic heart disease and congestive heart
More informationManagement of a Recipient with a Failed Kidney Transplant. Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania
Management of a Recipient with a Failed Kidney Transplant Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania Disclosures Grant support: Bristol-Myers and Squibb Pharmaceuticals,
More information02/27/2018. What is a Physician Home Champion? What skills does a home champion need to have?
HOME HEMODIALYSIS SYMPOSIUM ANNUAL DIALYSIS CONFERENCE 2018 HOW CAN WE FOSTER MORE PHYSICIAN CHAMPIONS? Joel D. Glickman, M.D. Director, Home Dialysis Programs Professor of Clinical Medicine University
More informationNew Zealand. Dialysis and Transplantation Audit
New Zealand Dialysis and Transplantation Audit Report for New Zealand Nephrology Services on behalf of the National Renal Advisory Board Grant Pidgeon Standards and Audit Subcommittee July 2012 Establishment
More informationDialysis Event Protocol
Dialysis Event Protocol Introduction In 2009, more than 370,000 patients were treated with maintenance hemodialysis in the United States. 1 Hemodialysis patients require a vascular access, which can be
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 10: Dialysis Providers In 2013, collectively the three large dialysis organizations treated 71% of patients in 67% of all dialysis units. In the Small Dialysis
More informationChapter 6: Mortality. Introduction 2016 USRDS ANNUAL DATA REPORT VOLUME 2 ESRD IN THE UNITED STATES
Chapter 6: Mortality In 2014, adjusted mortality rates for ESRD, dialysis, and transplant patients, were 136, 166, and 30, per 1,000 patient-years, respectively. By dialysis modality, mortality rates were
More informationMIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai
MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai i Postgraduate Training Program at Chubu Hospital, Okinawa,
More informationPeritoneal Dialysis Adequacy: Not Just Small- Solute Clearance
Advances in Peritoneal Dialysis, Vol. 24, 2008 Rajesh Yalavarthy, Isaac Teitelbaum Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance Two indices of small-solute clearance, Kt/V urea and creatinine
More informationTreatment choices for someone with Stage 5 kidney disease are:
Information for patients about advanced kidney disease Dialysis and non-dialysis treatments DOCUMENT PREPARED FOR This information is to help you understand some key issues about dialysis; it is designed
More informationMORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS
MORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS COMPARISON OF MORTALITY IN ALL PATIENTS ON DIALYSIS, PATIENTS ON DIALYSIS AWAITING TRANSPLANTATION, AND RECIPIENTS OF A FIRST CADAVERIC TRANSPLANT
More informationPresternal Catheter Design An Opportunity to Capitalize on Catheter Immobilization
Advances in Peritoneal Dialysis, Vol. 26, 2010 Dale G. Zimmerman Presternal Catheter Design An Opportunity to Capitalize on Catheter Immobilization Effective immobilization of the peritoneal catheter has
More informationChapter IV. The USRDS Dialysis Morbidity and Mortality Study (Wave 2) USRDS 1997 Annual Data Report USRDS Dialysis Morbidity and Mortality (Wave 2)
Annual Data Report USRDS Dialysis Morbidity and Mortality (Wave 2) Chapter IV The USRDS Dialysis Morbidity and Mortality Study (Wave 2) T Key Words: Residual renal function Automated peritoneal dialysis
More informationChapter 9: Cardiovascular Disease in Patients With ESRD
Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in adult ESRD patients, with atherosclerotic heart disease and congestive heart failure being the most common conditions
More informationManagement of End Stage Renal Disease-Bangladesh Perspective
Send Orders for Reprints to reprints@benthamscience.net 108 The Open Urology & Nephrology Journal, 2014, 7, 108-112 Management of End Stage Renal Disease-Bangladesh Perspective Harun Ur Rashid * Open Access
More informationDifference in practical dialysis therapy between East Asia and US/EU
Difference in practical dialysis therapy between East Asia and US/EU Jer-Ming Chang. M.D., Ph.D. 1 Professor, Attending physician, Kaohsiung Medical University Hospital; 2 Secretary General, Taiwan Society
More informationREIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange
REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange Agenda History of the Medicare ESRD Program Cost of Care for ESRD Patients
More informationQuality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care
Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE:
More informationThe vexing problem of suboptimal initiation of dialysis: Can we do better?
Budapest Nephrology School August 30, 2010 The vexing problem of suboptimal initiation of dialysis: Can we do better? David C Mendelssohn Disclosures 2007 2010 Speaker Fees: Amgen, Ortho Biotech, Genzyme,
More informationUrgent start PD: What is it, does it work, and how can we support it?
Urgent start PD: What is it, does it work, and how can we support it? Micheli Bevilacqua, MD, FRCPC Nephrologist, FHA Clinical Assistant Professor, UBC Division of Nephrology Disclosures I have no conflicts
More informationOptions in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology
Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology CKD Classification Stage Description GFR (ml/min/1.73.m2) 1 Kidney
More informationJVA ISSN Hemodialysis vascular access management in the Netherlands. Introduction ORIGINAL ARTICLE
JVA ISSN 1129-7298 J Vasc Access 2015; 16 (Suppl 9): S11-S15 DOI: 10.5301/jva.5000366 ORIGINAL ARTICLE Hemodialysis vascular access management in the Netherlands Jan H.M. Tordoir 1, Magda M. van Loon 1,
More information2008 Dialysis Facility Report
iii Purpose of the Report Enclosed is the (DFR) for this facility, based on data from the Centers for Medicare & Medicaid Services (CMS). This DFR includes data specific to provider number(s): 102844 These
More informationThe Renal Physicians Association Quality Improvement Registry
In collaboration with CECity The Renal Physicians Association Quality Improvement Registry This registry is approved by CMS as a Qualified Clinical Data Registry (QCDR) for Eligible Professionals and GPRO
More informationMETABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle
METABOLISM AND NUTRITION WITH PD OBESITY Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 Body Size in Patients New to Dialysis United States Body Mass Index, kg/m2 33 31
More informationAcute Start Dialysis: Navigating for our Patients
Acute Start Dialysis: Navigating for our Patients Innovative Nursing Roles Skipper: Mina Kashani RN(EC), MN, C Neph (C), S.S. St Michael s First Mate: Diane Watson, RN(EC), C Neph (C), S.S. Toronto General
More informationThe pattern of choosing dialysis modality and related mortality outcomes in Korea: a national population-based study
ORIGINAL ARTICLE Korean J Intern Med 2017;32:699-710 The pattern of choosing dialysis modality and related mortality outcomes in Korea: a national population-based study Hyung Jong Kim 1, Jung Tak Park
More informationKIDNEY FAILURE TREATMENT OPTIONS Choosing What s Best For You
KIDNEY FAILURE TREATMENT OPTIONS Choosing What s Best For You What Kidneys Do The kidneys are a pair of bean shaped organs located below your ribcage near the middle of your back. Kidneys play a vital
More informationNursing Care of the Dialysis Patient. Adrian Hordon, MSN, RN
Nursing Care of the Dialysis Patient Adrian Hordon, MSN, RN Understand principles of hemodialysis Recognize different access ports Identify side effects and complications Discuss nursing care for pre and
More informationManagement of a Recipient with a Failed Kidney Transplant. Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania
Management of a Recipient with a Failed Kidney Transplant Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania Objectives Epidemiology of transplant failure Timing of dialysis
More informationIncreased peritoneal dialysis utilization and improved patient survival over a 20-year period: data from a Portuguese Peritoneal Dialysis Unit
ORIGINAL ARTICLE Port J Nephrol Hypert 2016; 30(2): 113-120 Advance Access publication 30 January 2016 Increased peritoneal dialysis utilization and improved patient survival over a 20-year period: data
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Level of renal function at which to initiate dialysis GUIDELINES
Level of renal function at which to initiate dialysis Date written: September 2004 Final submission: February 2005 GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR
More informationAdvances in Peritoneal Dialysis, Vol. 23, 2007
Advances in Peritoneal Dialysis, Vol. 23, 2007 Antonios H. Tzamaloukas, 1,2 Aideloje Onime, 1,2 Dominic S.C. Raj, 2 Glen H. Murata, 1 Dorothy J. VanderJagt, 3 Karen S. Servilla 1,2 Computation of the Dose
More informationUnderstanding Dialysis Facility Compare: Driving Informed Decision Making
Understanding Dialysis Facility Compare: Driving Informed Decision Making Elena K Balovlenkov Joel Andress Stephanie Glier Celeste Lee February 4, 2015 Overview Background Dialysis Facility Compare (DFC)
More informationChanging the Paradigm from Contraction of Peritoneal Dialysis Programs to Increasing Prevalent Peritoneal Dialysis Numbers
Advances in Peritoneal Dialysis, Vol. 29, 2013 Jennifer Cross, Andrew Davenport Changing the Paradigm from Contraction of Peritoneal Dialysis Programs to Increasing Prevalent Peritoneal Dialysis Numbers
More informationCurrent treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database
ORIGINAL ARTICLE Korean J Intern Med 218;33:116-1168 https://doi.org/1.394/kjim.218.17 Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health
More informationImpact of Dialysis Modality on Survival after Kidney Transplant Failure
Article Impact of Dialysis Modality on Survival after Kidney Transplant Failure Jeffrey Perl,* Omar Hasan, Joanne M. Bargman, Depeng Jiang, Yingbo Na, John S. Gill, and S. Vanita Jassal Summary Background
More information02/27/2018. About half million people in the US with ESRD. HD is currently more prevalent than PD
Anil S. Paramesh, MD, FACS Professor of Surgery, Urology and Pediatrics Tulane University School of Medicine Transplant Advisor, ESRD Network 13 First described in the 1920s Chronic PD initiated in 1960s
More informationIn-Depth Review. Peritoneal Dialysis First: Rationale
In-Depth Review Peritoneal Dialysis First: Rationale Kunal Chaudhary,* Harbaksh Sangha, and Ramesh Khanna Summary The use of peritoneal dialysis (PD) has become wide spread since the introduction of continuous
More informationYou can sleep while I dialyze
You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep
More informationDialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence
Nephrol Dial Transplant (2015) 30: 310 320 doi: 10.1093/ndt/gfu293 Advance Access publication 23 September 2014 Dialysis modality choice in diabetic with end-stage kidney disease: a systematic review of
More informationMeeting the Guidelines for End-of-Life Care
Advances in Peritoneal Dialysis, Vol. 22, 2006 Gillian Brunier, David M.J. Naimark, Michelle A. Hladunewich Meeting the Guidelines for End-of-Life Care The number of patients initiating dialysis in most
More informationThe Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival
ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,
More informationMeasure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care
Measure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY This is
More informationFIRST RENAL REPLACEMENT
FIRST RENAL REPLACEMENT THERAPY SELECTION IN DIABETIC PATIENTS Dr Cécile Couchoud (REIN registry, France) Davide Bolignano (ERBP, Italy) European Renal Best Practice Prof. Wim Van Biesen Chairman of ERBP
More informationCHAPTER 5. Haemodialysis. Kevan Polkinghorne Hannah Dent Aarti Gulyani Kylie Hurst Stephen McDonald
CHAPTER Haemodialysis Kevan Polkinghorne Hannah Dent Aarti Gulyani Kylie Hurst Stephen McDonald STOCK AND FLOW AUSTRALIA The annual stock and flow of HD patients during the period - is shown in Figures.,.
More information5. Indications for the use of urokinase in peritoneal dialysis associated peritonitis
5. Indications for the use of urokinase in peritoneal dialysis associated peritonitis Date written: February 2003 Final submission: July 2004 Guidelines (Include recommendations based on level I or II
More informationEvaluation and management of nutrition in children
Evaluation and management of nutrition in children Date written: May 2004 Final submission: January 2005 Author: Elisabeth Hodson GUIDELINES No recommendations possible based on Level I or II evidence
More informationHome Hemodialysis or Transplantation of the Treatment of Choice for Elderly?
Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Miklos Z Molnar, MD, PhD, FEBTM, FERA, FASN Associate Professor of Medicine Division of Nephrology, Department of Medicine University
More informationChapter 10: Dialysis Providers
Chapter 10: Dialysis Providers In 2014 the two largest dialysis organizations, Fresenius and DaVita, collectively treated 69% of patients in 65% of all dialysis units (Figure 10.2). Nearly 90% of all dialysis
More informationResearch. Changes in survival among elderly patients initiating dialysis from 1990 to 1999
Changes in survival among elderly patients initiating dialysis from 1990 to 1999 Research Sarbjit Vanita Jassal MB BCh MD, Lilyanna Trpeski MPH MD, Naisu Zhu MD, Stanley Fenton MD, Brenda Hemmelgarn PhD
More information2011 Dialysis Facility Report SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE Dialysis Facility Report SAMPLE
Purpose of the Report Enclosed is the (DFR) for your facility, based on data from the Centers for Medicare & Medicaid Services (CMS). This DFR includes data specific to CCN(s): 999999 These data could
More informationDeveloping a Quality Assurance Performance Improvement (QAPI) Program at Your Dialysis Center Rudolph P. Valentini, M.D. Associate Professor of Pediatrics Director of Dialysis Services Vice Chief of Staff
More informationMoney or Patient well-being
John A. Navis President, Janin Group Inc john@janingroup.com TEL: 630-554-5533 CELL: 630-240-3710 Money or Patient well-being 2 3 4 Continual decisions by you and everyone involved focusing on the goal
More information